Skip to main content
Caplight Logo









Spentys

Spentys

Private
BrusselsHealthcare & Life Scienceshttps://www.spentys.com/

Last Round

Series A

Nov 1, 2023

Total Funding Raised

$5.71M

Company Overview

Spentys is a health technology company that provides an automated 3D scanning and printing platform for the design and manufacturing of custom orthopedic immobilization devices.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing, Medical Imaging

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

3D printingorthopedic castsdigital orthopedicsmedical 3D scanningorthotics and prostheticsO&Pmedical device softwareorthopedic splintsdigital castingdesign automationvertical SaaS3D printed castclinical workflowmedical CADcustom orthotics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spentys Comparables

Compare Spentys with similar companies based on industry and business-model similarity.

Spentys comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Manometric
87%
Twikit
85%
Mecuris
82%

Spentys Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 1, 2023
SeedMar 17, 2020
AngelFeb 1, 2019

Key People

Founding team and executive leadership

Louis-Philippe Broze

Co-Founder and CEO

Founding Team

Pieter Maes

Chief Technology Officer

Executive Team

Alice Rouvez

Chief Product Officer

Executive Team

Spentys Investors

Notable investors and investment history

Spentys investors
InvestorRounds
The Innovation FundSeed
finance&invest.brusselsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 7, 2026

    Monthly visitors grew 48% MoM.

  • Mar 1, 2026

    Monthly visitors increased 49% MoM.

Spentys Filings

Explore SEC and related filing metadata, where available.

Spentys filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Spentys's valuation, stock price, and market status.

Is Spentys a public or private company?

Spentys is a private company.

What is the current stock price of Spentys?

Spentys is a private company with no public stock price. No recent secondary market data is available.

How much is Spentys worth (valuation)?

Valuation information for Spentys is not publicly available.

Can I buy Spentys stock?

Spentys shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Spentys's last funding round?

Spentys's most recent funding round was Series A on November 1, 2023.

Who are the main investors in Spentys?

Key investors in Spentys include The Innovation Fund, finance&invest.brussels.

Will Spentys IPO soon?

No public IPO plans have been announced for Spentys.

How can I track Spentys secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Spentys's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBrussels
Employee Range19
Year Founded2017
Last FundingNov 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?